Skip to main content
Tell your legislator to say NO to the Governor’s permanent Corporate Transit Fee. SEND A MESSAGE

Opinion: Labor Leader Greg Lalevee on “Workers Win When Jersey Drug Companies Innovate” The Record/ published the following opinion piece by Greg Lalevee, business manager of the International Union of Operating Engineers Local 825: New Jersey’s nickname, “Medicine Chest of the World,” is backed up by the numbers. Our state is home to more than 3,000 life sciences establishments. Thirteen of the world’s top 20 biopharmaceutical companies have made the Garden State their U.S. headquarters. These firms are innovating and saving lives every day – and they couldn’t do it without help from supportive government policies and New Jersey’s well-trained and talented union workforce.


Rutgers-New Brunswick Rated One of Top 100 Research Universities in the World; Ranked No. 31 in U.S. NJBIZ reported that Rutgers-New Brunswick was one of 37 universities in the United States to be ranked among the Top 100 research-intensive universities in the world, according to the prestigious CWTS Leiden Rankings. Rutgers ranked No. 77 in the world, but No. 31 among schools based in the United States. Rutgers was behind Cornell (No. 26), Washington University in St. Louis (27) and New York University (29). However, Rutgers was ahead of Vanderbilt (32), Southern California (34), Emory University (35) and the University of Chicago (36).


New Jersey Business Magazine’s June 2017 Issue Spotlights “The Innovative State”
The annual June 2017 “Innovative State” edition of New Jersey Business magazine, a publication of New Jersey Business & Industry Association (NJBIA), includes an array of articles spotlighting the many high-tech industries, academic institutions and organizations that make the state a true center for research and development. A separate feature article examines employee benefits, and an entire special section is devoted to what colleges and universities offer the business community in the innovation sphere.
Opinion: Allergan Chief Brent L. Saunders on “Helping our Daughters Stick with STEM”

Brent L. Saunders, Chairman, President and Chief Executive Officer at Allergan plc, on June 21 wrote the following opinion piece on his CEO blog: As the CEO of a biopharma company that is focused on innovation for patients, I was struck recently by the scientific thinking and discovery happening at an event that might surprise you: my daughter’s high school science fair. The projects tackled scientific mysteries such as why different shades of color trigger a neurological response including mood, how mathematical statistics explain the so-called “Birthday Paradox” and more.


NPR All Tech Considered: Before Silicon Valley, New Jersey Reigned as Nation’s Center of Innovation Laura Sydell on June 5 reported on National Public Radio (NPR) on New Jersey’s history of innovation: People from New Jersey are used to defending their state. But, in fact, New Jersey has a history to brag about. Thomas Edison invented the light bulb, the phonograph and the movie camera there. Many decades later, Bell Labs invented the transistor in the state. Geography favored New Jersey. On one end, it borders New York City, and on the other end is Philadelphia. That means easy access to Wall Street financing, transportation and industry headquarters.


NJIT’s Center for Pre-College Programs Receives Upward Bound Federal Grants The United States Department of Education (USDOE) has awarded the Center for Pre-College Programs (CPCP) at New Jersey Institute of Technology two grants for its Upward Bound program. CPCP received $503,928 for year one of a five-year continuation grant. It will enable the center to continue to serve 113 public-school students at Barringer Academy of the Arts & Humanities, Marion P. Thomas Charter and Malcolm X. Shabazz High Schools in Newark. This grant has been serving the Newark Community for over 25 years.
New Jersey Innovation Institute Introduces Two Groundbreaking Biopharmaceutical Centers Companies in every sector are realizing that manufacturing matters. For the biopharmaceutical industry, innovation is not about reducing unit part costs; instead, process technology is a strategic tool to reduce time to market, ensure consistent product quality and streamline regulatory approval. As rapidly as science is advancing drug discovery, so too, must production technology keep pace. But where will such innovation happen? The New Jersey Innovation Institute (NJII) is answering this question.


Ex-Roche Campus Reinvented as “On3” Science Center; Developer Seeks To Create Mini-Metropolis in the Suburbs’ for Life Sciences Owen Proctor reports in The Record/ that the former Hoffmann-La Roche campus that borders Clifton and Nutley has a new name. “On3” seeks to incorporate living, working and playing in the Route 3 site, according to Prism Capital Partners’ principal Eugene Diaz. He described the redevelopment as “a mini-metropolis in the suburbs.” The firm wants to reinvent the 116-acre campus that the pharmaceutical giant began vacating in 2012, creating a synergy among like-minded businesses geared toward life sciences.